Catalyst Wire Dossier Catalyst Wire Dossier

V212 vaccine

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V212 vaccine, covering 2011-04-13 to 2011-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003) [Phase 1]

See pricing